SEARCH

SEARCH BY CITATION

References

  • Bardelli, T., Donati, M. A., Gasperini, S., Ciani, F., Belli, F., Blau, N., Morrone, A. & Zammarchi, E. (2002) Two novel genetic lesions and a common BH4-responsive mutation of the PAH gene in Italian patients with hyperphenylalaninemia. Mol Genet Metab 77, 260266.
  • Blau, N. & Erlandsen, H. (2004a) The metabolic and molecular bases of tetrahydrobiopterin-responsive phenylalanine hydroxylase deficiency. Mol Genet Metab 82, 101111.
  • Blau, N. & Scriver, C. R. (2004b) New approaches to treat PKU: how far are we? Mol Genet Metab 81, 12.
  • Blau, N., Thöny, B., Cotton, R. G. H. & Hyland, K. (2001), Disorders of tetrahydrobiopterin and related biogenic amines. In: The metabolic and molecular basis of inherited disease (eds. C.R.Scriver, A.L.Beaudet, W.S.Sly & D.Valle), pp. 17251776. Basel : McGraw Hill.
  • Bosco, P., Ceratto, N., Cali, F., Goltsov, A. A., Eisensmith, R. C., Novelli, G., Dalla Piccola, B. & Romano, V. (1996) RFLP discordance in a PKU family due to a deletion in the PAH gene. Turk J Pediatr 38, 497504.
  • Castaldo, G., Polizzi, A., Tomaiuolo, R., Cazeneuve, C., Girodon, E., Santostasi, T., Salvatore, D., Raia, V., Rigillo, N., Goossens, M. & Salvatore, F. (2005) Comprehensive cystic fibrosis mutation epidemiology and haplotype characterization in a southern Italian population. Ann Hum Genet 69, 1524.
  • Chien, Y. H., Chiang, S. C., Huang, A., Chou, S. P., Tseng, S. S., Huang, Y. T. & Hwu, W. L. (2004) Mutation spectrum in Taiwanese patients with phenylalanine hydroxylase deficiency and a founder effect for the R241C mutation. Hum Mutat 23, 206.
    Direct Link:
  • Desviat, L. R., Perez, B., Belanger-Quintana, A., Castro, M., Aguado, C., Sanchez, A., Garcia, M. J., Martinez-Prado, M. & Ugarte, M. (2004) Tetrahydrobiopterin responsiveness: results of BH4 loading test in 31 Spanish PKU patients and correlation with their genotype. Mol Genet Metab 83, 157162.
  • Dipple, K. M. & McCabe, E. R. B. (2000) Modifier genes convert “simple” mendelian disorders to complex traits. Mol Genet Metab 71, 4350.
  • Erlandsen, H., Patch, M. G., Gamez, A., Straub, M. & Stevens, R. C. (2003) Structural studies on phenylalanine hydroxylase and implications toward understanding and treating phenylketonuria. Pediatrics 112, 15571565.
  • Erlandsen, H. & Stevens, R. C. (2001) A structural hypothesis for BH4 responsiveness in patients with mild forms of hyperphenylalaninemia and phenylketonuria. J Inherit Metab Dis 24, 213230.
  • Giannattasio, S., Dianzani, I., Lattanzio, P., Spada, M., Romano, V., Cali, F., Andria, G., Ponzone, A., Marra, E. & Piazza, A. (2001) Genetic heterogeneity in five Italian regions: Analysis of PAH mutations and minihaplotypes. Hum Hered 52, 154159.
  • Goltsov, A. A., Eisensmith, R. C., Konecki, D. S., Lichter-Konecki, U. & Woo, S. L. C. (1992) Association between mutations and a VNTR in the human phenylalanine hydroxylase gene. Am J Hum Genet 51, 627636.
  • Goltsov, A. A., Eisensmith, R. C., Naughton, E. R., Jin, L., Chakraborty, R. & Woo, S. L. C. (1993) A single polymorphic STR system in the human phenylalanine hydroxylase gene permits rapid prenatal diagnosis and carrier screening for phenylketonuria. Hum Mol Genet 2, 577581.
  • Guldberg, P., Rey, F., Zschocke, J., Romano, V., Francois, B., Michiels, L., Ullrich, K., Hoffmann, G. F., Burgard, P., Schmidt, H., Meli, C., Riva, E., Dianzani, I., Ponzone, A., Rey, J. & Guttler, F. (1998) A European multicenter study of phenylalanine hydroxylase deficiency: Classification of 105 mutations and a general system for genotype-based prediction of metabolic phenotype. Am J Hum Genet 63, 7179.
  • Guthrie, R. & Susi, A. (1963) A simple phenylalanine method for detecting Phenylketonuria in large populations of newborn infants. Pediatrics 32, 338343.
  • Kleiman, S., Vanagaite, L., Bernstein, J., Schwartz, G., Brand, N., Elitzur, A., Woo, S. L. & Shiloh, Y. (1993) Phenylketonuria: variable phenotypic outcomes of the R261Q mutation and maternal PKU in the offspring of a healthy homozygote. J Med Genet 30, 284288.
  • Pagani, F., Stuani, C., Tzetis, M., Kanavakis, E., Efthymiadou, A., Doudounakis, S., Casals, T. & Baralle, F. E. (2003) New type of disease causing mutations: the example of the composite exonic regulatory elements of splicing in CFTR exon 12. Hum Mol Genet 12, 11111120.
  • Rendine, S., Calafell, F., Cappello, N., Gagliardini, R., Caramia, G., Rigillo, N., Silvetti, M., Zanda, M., Miano, A., Battistini, F., Marianelli, L., Taccetti, G., Diana, M. C., Romano, L., Romano, C., Giunta, A., Padoan, R., Pianaroli, A., Raia, V., De Ritis, G., Battistini, A., Grzincich, G., Japichino, L., Pardo, F., Piazza, A. et al . (1997) Genetic history of cystic fibrosis mutations in Italy. I. Regional distribution. Ann Hum Genet 61, 411424.
  • Rivera, I., Cabral, A., Almeida, M., Leandro, P., Carmona, C., Eusebio, F., Tasso, T., Vilarinho, L., Martins, E., Lechner, M. C., Tavares de Almeida, I., Konecki, D. S. & Lichter-Konecki, U. (2000) The correlation of genotype and phenotype in Portuguese hyperphenylalaninemic patients. Mol Genet Metab 69, 195203.
  • Romano, V., Lio, D., Cali, F., Scola, L., Leggio, L., D'Anna, C., De Leo, G. & Salermo, A. (2001) A methodological strategy for PAH genotyping in populations with a marked molecular heterogeneity of hyperphenylalaninemia. Mol Cell Probes 15, 1319.
  • Salvatore, F., Scudiero, O., Castaldo, G. (2002) Genotype-phenotype correlation in cystic fibrosis: the role of modifier genes. Am J Med Genet 111, 8895.
  • Scriver, C. R., Hurtubise, M., Konecki, D., Phommarinh, M., Prevost, L., Erlandsen, H., Stevens, R., Waters, P. J., Ryan, S., McDonald, D. & Sarkissian, C. (2003) PAHdb 2003: what a locus-specific knowledgebase can do? Hum Mutat 21, 333344.
  • Scriver, C. R., Kaufman, S., Eisensmith, R. C. & Woo, S. L. C. (2001), The hyperphenylalaninemias. In: The metabolic and molecular basis of inherited disease (eds. C.R.Scriver, A.L.Beaudet, W.S.Sly & D.Valle), pp. 16671724. Basel : McGraw Hill.
  • Scriver, C. R. & Waters, P. J. (1999) Monogenic traits are not simple: Lessons from phenylketonuria. Trends Genet 15, 267272.
  • Spaapen, L. J. M. & Rubio-Gozalbo, M. E. (2003) Tetrahydrobiopterin-responsive phenylalanine hydroxylase deficiency, state of the art. Mol Genet Metab 78, 9399.
  • Taruscio, D., Falbo, V., Floridia, G., Salvatore, M., Pescucci, C., Cantafora, A., Marongiu, C., Baroncini, A., Calzolari, E., Cao, A., Castaldo, G., Bricarelli, F. D., Guanti, G., Nitsch, L., Pignatti, P. F., Rosatelli, C., Salvatore, F. & Zuffardi, O. (2004) Quality assessment in cytogenetic and molecular genetic testing: the experience of the Italian Project on Standardization and Quality Assurance. Clin Chem Lab Med 42, 915921.
  • Waters, P. J. (2003) How PAH gene mutations cause hyper-phenylalaninemia and why mechanism matters: insights from in vitro expression. Hum Mutat 21, 357369.
  • Zschocke, J. (2003) Phenylketonuria mutations in Europe. Hum Mutat 21, 345356.
  • Zschocke, J. & Hoffmann, G. F. (1999) Phenylketonuria mutations in Germany. Hum Genet 104, 390398.